John Price is a highly-skilled physician executive with extensive experience in drug development, risk management, and regulatory affairs. With 27 years of experience in the pharmaceutical industry, John has worked with various US-based global pharmaceutical companies, including big Pharma, consumer health and rare diseases, and a European Regulatory Agency. His expertise lies in driving effectiveness and efficiencies to avoid excessive costs when it comes to regulatory compliance. He is passionate about helping companies save valuable dollars, ensuring that resources are used efficiently for the development of future medicines. John has a broad educational background, including an MBChB, Medicine, a BSc in Pharmacology, and a Ph.D. in Clinical Pharmacology. He has served as the former VP of Global Pharmacovigilance and Drug Safety at Alexion Pharmaceuticals, Inc., and as a former VP at Johnson & Johnson, Independent Pharmaceutical Consultant, Pfizer Pharmaceuticals, Medicines Control Agency, UK, University of Cambridge, and Lothian Health Board, Scotland.